Peter C. Fusco

Peter C. Fusco

Auto-generated profile, based on publicly available information

Peter C. Fusco

Ann Yellowlees, Francis Bursa, and Kelly J. Fleetwood are affiliated with Quantics, in Edinburgh, Scotland, United Kingdom. Sue Charlton is affiliated with Public Health England (PHE), in Porton Down, Salisbury, United Kingdom. Karie J. Hirst, Ronggai Sun, and Peter C. Fusco are with PharmAthene, Inc., in Annapolis, Maryland. PCF is also affiliated with VaxInnate Corporation, in Cranbury, New Jersey

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Clinical and Experimental Vaccine Research
Verified
Journal Article
Open access
PDF file
BPBradford S. Powell
Bradford S. Powell
Alexander AndrianovAlexander Andrianov
Alexander Andrianov
PFPeter C. Fusco
Peter C. Fusco
Powell BS, et al. Clin Exp Vaccine Res. 2015 Jan;4(1):23-45. http://dx.doi.org/10.7774/cevr.2015.4.1.23

25 November 2015 in BioScience
Verified
Journal Article
Open access
PDF file
AYAnn Yellowlees
Ann Yellowlees
FBFrancis Bursa
Francis Bursa
KFKelly J. Fleetwood
Kelly J. Fleetwood
SCSue Charlton
Sue Charlton
KHKarie J. Hirst
Karie J. Hirst
PFPeter C. Fusco
Peter C. Fusco
Outliers within a bioassay are not uncommon, especially with animal models. Ordinary linear regression is sensitive to outliers; even a single outlier may compromise parallelism and other assay suitability criteria, skew the estimate of relative potency, or inflate its uncertainty. In this article, robust regression, which is less sensitive to outliers, is considered as an alternative. A comparison of ordinary linear with robust regression was conducted for 32 immunopotency assays; we also conducted a simulation study. Under ordinary linear regression, outliers flattened the slopes and inflated their variance. Under robust regression, slopes were less sensitive to outliers. Assay failures due to lack of dose response were reduced from 9% to 1%, failures due to nonparallelism were reduced from 18% to 2%, and the precision of the relative potency estimate improved by 9%. We conclude that robust regression is a more appropriate approach for bioassay data containing outliers than ordinary linear regression or excluding outliers.